Hongyun Zhao
ORCID: 0000-0002-1251-3888Also affiliated with Sun Yat-sen University Cancer Center
Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Why this DataRank?
An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.
Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.
Read the full methodology →Papers
Driven by 5 papers. Top paper: “A multicenter, open-label phase Ib/II study of cadonilimab (anti PD-1 and CTLA-4 bispecific antibody) monotherapy in previously treated advanced non–small-cell lung cancer (AK104-202 study)”.
Yuxiang Ma, Yun Fan, Jianya Zhou, Nong Yang, Qitao Yu +8 more
Kenneth D. Swanson, Bin Zheng, Hongyun Zhao
Da Teng, Lifeng Yang, Xincheng Xu, Jiajia Chen, Teng‐Jia Jiang +14 more
Vaishnavi Sambandam, Anne M. Fernandez, Hongyun Zhao, Tuhina Mazumdar, Li Shen +7 more
Yong-ju Liang, Hongbing Huang, Hongyun Zhao, Chung‐Pu Wu, Fang Wang +10 more